Mastek Capital Structure Change
Bandhan Mutual Fund acquired 18,000 Mastek shares in the open market on September 15, 2026, raising its stake to 5.0544%. No transaction price is disclosed.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
32 announcements with these filters
Bandhan Mutual Fund acquired 18,000 Mastek shares in the open market on September 15, 2026, raising its stake to 5.0544%. No transaction price is disclosed.
Mastek held its 44th Annual General Meeting on September 07, 2026. The meeting covered adoption of financial statements, dividend declarations, and director re-appointment.
Mastek Limited announced that Ms. Marilyn Jones has ceased to be an Independent Director upon the completion of her tenure, effective September 04, 2026.
Mastek Limited allotted 3,969 equity shares following the exercise of vested options under its ESOP Plan VII. Consequently, the company's paid-up share capital increased to Rs. 15,50,31,880.
Mastek Limited completed the sale of its commercial building at Mahindra World City, Chennai for ₹60 Crore. The transaction is not a related party deal.
Mastek Limited issued a letter to shareholders providing web links and QR codes to access the Annual Report for the financial year 2025-26.
Mastek Ltd has submitted its Annual Report for FY 2025-26 and the notice for its 44th Annual General Meeting.
Mastek will hold its 44th AGM on September 7, 2026. The company has fixed August 31, 2026, as the record date for the final dividend payment.
Mastek has entered into a strategic Platinum Partnership with Innovaccer. The collaboration aims to accelerate AI-powered digital healthcare transformation across global markets.
Mastek delivered steady Q1 FY27 growth led by UK and North America, though Middle East geopolitical crises caused volatility and margin pressure. Management is aggressively pivoting toward an AI-first transformation strategy.
Mastek Limited announced its Q1 FY27 results, reporting revenue of ₹985.3 crore and a net profit of ₹105.9 crore for the quarter ended June 30, 2026.
Mastek Limited announced the approval of its unaudited financial results for the quarter ended June 30, 2026. The board also approved amendments to its insider trading code.
HDFC Mutual Fund increased its stake in Mastek Ltd to 5.06% through an open market acquisition. The purchase of 86,746 shares crossed the 5% disclosure threshold.
Mastek Limited allotted 1,625 equity shares under its ESOP scheme. This allotment increased the company's total paid-up share capital to Rs. 15,50,12,035.
Mastek Limited allotted 1,625 equity shares under its Employee Stock Option Plans. This allotment increases the company's total paid-up share capital to ₹15.50 Crore.
MASTEK Ltd filed its Shareholding Pattern for the quarter ending 30 June 2026, detailing holdings across promoters, institutions and public investors. No monetary transaction is disclosed.
Mastek Ltd will hold a Board Meeting on July 21, 2026, to approve Q1 FY27 results. An earnings call is scheduled for July 22, 2026.
Mastek has partnered with Yanbu Cement Company to digitise its production-to-dispatch operations using IoT and AI solutions. The collaboration aims to boost efficiency and reduce manual processes.
Mastek received an Income Tax Assessment Order with ₹123.58 Crore in income additions. The company intends to appeal, citing computation errors and non-material financial impact.
Mastek appointed Amit Gajwani as Chief Operating Officer, succeeding Prameela Kalive. The move strengthens leadership as the firm accelerates its AI-first digital transformation strategy.
Mastek appointed Amit Gajwani as Chief Operating Officer effective May 18, 2026. Current COO Prameela Kalive will superannuate on June 30, 2026, after facilitating transitions.
Mastek Limited allotted 3,442 equity shares under its Employee Stock Option Plan. The allotment increases paid-up capital to ₹15.50 Crore, supporting employee incentive schemes.
Gammon India Limited confirmed it does not meet the criteria for being identified as a 'Large Corporate' (LC) as of March 31, 2026. This classification is due to its credit rating being below 'AA'. Consequently, the specific debt-raising disclosure requirements for Large Corporates do not apply to the company for the financial year 2026-27.
Mastek Limited has entered into an MOU with Caresoft Mobility Private Limited to sell its commercial building at Mahindra World City, Chennai, for ₹60 Crore. The transaction involves a 1,57,233 Sq. Ft. built-up area on 15.50 acres of leased land and is subject to necessary SEBI and regulatory approvals.
Mastek reported a stable Q4FY26 with $103.5M revenue and 16.1% EBITDA margin. Strategy shifts toward AI-led verticalization and domain-specific growth.
Mastek delivered a stable Q4 with 3.6% sequential revenue growth despite geopolitical headwinds, though healthcare saw a timing-related dip.
Mastek Limited clarified discrepancies between its PDF and XBRL financial results for FY25. The company explained that certain line items were disclosed separately in the PDF for clarity but consolidated under 'Other Income' in XBRL due to taxonomy requirements. Total income remains consistent across both formats at ₹73.35 Crore for the full year.
Mastek reported Q4FY26 revenue of ₹938.0 Cr and 11.0% PAT margin. The company is pivoting to an 'AI-first' strategy, closing 25+ AI deals this quarter.
Mastek Limited's Board has recommended a final dividend of Rs. 16 per equity share for the financial year 2025-2026. The record date and General Meeting details will be announced later. This recommendation is subject to shareholder approval.
Mastek Ltd approved its FY25-26 annual audited results, reporting a standalone profit before tax of ₹23.16 Crore. The Board also recommended a final dividend of 320% (₹16 per share), bringing the total dividend for the year to ₹24 per share.